What is the management plan for a patient with normal triglycerides and high High-Density Lipoprotein (HDL) cholesterol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Normal Triglycerides and High HDL Cholesterol

No specific treatment is needed for a patient with normal triglycerides (44 mg/dL) and high HDL cholesterol (92 mg/dL), as this lipid profile is associated with reduced cardiovascular risk.

Understanding the Lipid Profile

The presented lipid profile shows:

  • Triglycerides: 44 mg/dL (normal is <150 mg/dL)
  • HDL cholesterol: 92 mg/dL (well above the recommended >40 mg/dL for men and >50 mg/dL for women)

This combination represents an optimal lipid profile from a cardiovascular risk perspective. Low triglycerides and high HDL cholesterol are associated with a reduced risk of ischemic heart disease 1.

Clinical Significance

Cardiovascular Risk Implications

  • The low TG-high HDL-C pattern is associated with a significantly lower risk of cardiovascular disease, even in the presence of other conventional risk factors 1.
  • Research shows that individuals with low triglycerides (≤97 mg/dL) and high HDL-C (≥57 mg/dL) have a substantially reduced risk of ischemic heart disease (4.0-5.1%) compared to those with high TG-low HDL-C (9.8-16.4%) 1.
  • This favorable lipid profile is protective against atherosclerosis and cardiovascular events 2.

No Need for Lipid-Lowering Therapy

  • Current guidelines do not recommend treatment to lower normal triglycerides or to reduce HDL cholesterol that is above target levels 3, 4.
  • The European Society of Cardiology and European Atherosclerosis Society guidelines indicate that HDL-C is a risk marker but not a primary treatment target 3.

Recommended Approach

Assessment of Overall Cardiovascular Risk

  1. Evaluate for other cardiovascular risk factors despite the favorable lipid profile:

    • Blood pressure
    • Smoking status
    • Family history of premature cardiovascular disease
    • Physical activity level
    • Body mass index and waist circumference
    • Fasting glucose/HbA1c
  2. Calculate 10-year cardiovascular risk using an appropriate risk calculator.

Management Recommendations

  • Maintain current lifestyle habits that are contributing to this favorable lipid profile.
  • Continue regular physical activity, which helps maintain high HDL-C levels 4.
  • Maintain a heart-healthy diet low in saturated and trans fats 4.
  • If the patient smokes, encourage smoking cessation, as this can further increase HDL-C levels by up to 30% 4.
  • Moderate alcohol consumption may be beneficial for maintaining HDL-C levels, but should not be recommended solely for this purpose 4.

Monitoring

  • Annual lipid profile testing is reasonable to ensure the favorable pattern persists.
  • If other cardiovascular risk factors are present, they should be managed according to current guidelines, regardless of the favorable lipid profile.

Special Considerations

Metabolic Health Assessment

  • Even with this favorable lipid profile, consider screening for insulin resistance or metabolic syndrome, as these conditions can exist despite optimal lipid values.
  • The TG/HDL-C ratio (in this case 44/92 = 0.48) is well below 1.8, which further confirms low insulin resistance and reduced cardiovascular risk 2.

Genetic Factors

  • Extremely high HDL-C levels (>100 mg/dL) may occasionally be associated with genetic variants that don't necessarily confer the expected cardioprotective effect.
  • However, for most patients, this lipid profile represents an optimal cardiovascular risk profile that should be maintained rather than treated.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dyslipidemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.